Adenosine as an endogenous adaptive cardiac antihypertrophic and antiremodelling factor

Cardiac Adaptations: Molecular Mechanisms

Volumn 4, Issue , 2013, Pages 403-414

  Karmazyn, Morris ^a   Gan, Xiaohong Tracey ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Adenosine; Adenosine receptor; Alkaline phosphatases; Antihypertrophic effect; CD73; Myocardial calcification

Indexed keywords

EID: 84939913249     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-5203-4_21     Document Type: Chapter

References (70)

1. Wainwright CL, Parratt JR (1988) An antiarrhythmic effect of adenosine during myocardial ischaemia and reperfusion. Eur J Pharmacol 145:183-194
2. Norton ED, Jackson EK, Virmani R, Forman MB (1991) Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow. Am Heart J 122:1283-1291
3. Norton ED, Jackson EK, Turner MB, Virmani R, Forman MB (1992) The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury. Am Heart J 123:332-338
4. Tsuchida A, Miura T, Miki T, Shimamoto K, Isimura O (1992) Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 26:456-461
5. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA et al (1991) Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84:350-356
6. Thornton JD, Liu GS, Olsson RA, Downey JM (1992) Intravenous pretreatment with A1- selective adenosine analogues protects the heart against infarction. Circulation 85:659-665
7. Mullane K (1992) Myocardial preconditioning. Part of the adenosine revival. Circulation 85:845-847
8. Galinanes M, Hearse DJ (1992) Exogenous adenosine accelerates recovery of cardiac function and improves coronary flow after long-term hypothermic storage and transplantation. J Thorac Cardiovasc Surg 104:151-158
9. Bolling SF, Groh MA, Mattson AM, Grinage RA, Gallagher KP (1992) Acadesine [AICA- riboside] improves postischemic cardiac recovery. Ann Thorac Surg 54:93-98
10. Collis MG (1983) Evidence for an A1-adenosine receptor in the guinea-pig atrium. Br J Pharmacol 78:207-212
11. Martens D, Lohse MJ, Rauch B, Schwabe U (1987) Pharmacological characterization of A1 adenosine receptors in isolated rat ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 336:342-348
12. Romano FD, MacDonald SG, Dobson JG (1989) Adenosine receptor coupling to adenylate cyclase of rat ventricular myocyte membranes. Am J Physiol 257:H1088-H1095
13. Xu D, Kong HY, Liang BT (1992) Expression and pharmacological characterization of a stimulatory subtype of adenosine receptor in fetal chick ventricular myocytes. Circ Res 70:56-65
14. Dennis D, Jacobson K, Belardinelli L (1992) Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node. Am J Physiol 262:H661-H671
15. Lerman BB, Belardinelli L (1991) Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation 83:1499-1509
16. Tracey WR, Magee W, Masamune H, Oleynek JJ, Hill RJ (1998) Selective activation of adenosine A3 receptors with N6-[3-chlorobenzyl]-5'-N-methylcarboxamidoadenosine [CB- MECA] provides cardioprotection via KATP channel activation. Cardiovasc Res 40:138-145
17. Tracey WR, Magee W, Masamune H, Kennedy SP, Knight DR et al (1997) Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc Res 33:410-415
18. Pang T, Gan XT, Freeman DJ, Cook MA, Karmazyn M (2010) Compensatory upregulation of the adenosine system following phenylephrine-induced hypertrophy in cultured rat ventricular myocytes. Am J Physiol Heart Circ Physiol 298:H545-H553
19. Xia Y, Rajapurohitam V, Cook MA, Karmazyn M (2004) Inhibition of phenylephrine induced hypertrophy in rat neonatal cardiomyocytes by the mitochondrial KATP channel opener diazoxide. J Mol Cell Cardiol 37:1063-1067
20. Grover GJ, Sleph PG, Dzwonczyk S (1990) Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. J Cardiovasc Pharmacol 16:853-864
21. Grover GJ, Dzwonczyk S, Parham CS, Sleph PG (1990) The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc Drugs Ther 4:465-474
22. Escande D, Cavero I (1992) K+ channel openers and 'natural' cardioprotection. Trends Pharmacol Sci 13:269-272
23. Gross GJ, Auchampach JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70:223-233
24. Kirsch GE, Codina J, Birnbaumer L, Brown AM (1990) Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 259:H820- H826
25. Cohen MV, Baines CP, Downey JM (2000) Ischemic preconditioning: from adenosine receptor of KATP channel. Annu Rev Physiol 62:79-109
26. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD et al (2011) American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2011 update: a report from the American heart association. Circulation, vol 123, pp e18-e209 (Erratum in Circulation, vol 123, p e240)
27. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA (2006) Controversies in ventricular remodelling. Lancet 367:356-367
28. Sun Y (2009) Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res 81:482-490
29. Frantz S, Bauersachs J, Ertl G (2009) Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res 81:474-481
30. Javadov S, Karmazyn M (2007) Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 20:1-22
31. Katz AM (2000) The hypertrophic response: programmed cell death. In: Heart failure. Pathophysiology, molecular biology, and clinical management. Lippincott Williams & Wilkins, Philadelphia, pp 173-226
32. Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45-79
33. Frey N, Katus HA, Olson EN, Hill JA (2004) Hypertrophy of the heart: a new therapeutic target? Circulation 109:1580-1589
34. Hardt SE, Sadoshima J (2004) Negative regulators of cardiac hypertrophy. Cardiovasc Res 63:500-509
35. Funaya H, Kitakaze M, Node K, Minamino T, Komamura K et al (1997) Plasma adenosine levels increase in patients with chronic heart failure. Circulation 95:1363-1365
36. Kitakaze M, Minamino T, Node K, Koretsune Y, Komamura K et al (1998) Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure. Cardiovasc Drugs Ther 12:307-309
37. Chung ES, Perlini S, Aurigemma GP, Fenton RA, Dobson JG et al (1998) Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. J Hypertens 16:1813-1822
38. Kitakaze M, Hori M (2000) Adenosine therapy: a new approach to chronic heart failure. Opin Investig Drugs 9:2519-2535
39. Dubey RK, Gillespie DG, Jackson EK (1999) Adenosine inhibits collagen and total protein synthesis in vascular smooth muscle cells. Hypertension 33:190-194
40. Wakeno M, Minamino T, Seguchi O, Okazaki H, Tsukamoto O et al (2006) Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats. Circulation 114:1923-1932
41. Fassett JT, Xu X, Hu X, Zhu G, French J et al (2009) Adenosine regulation of microtubule dynamics in cardiac hypertrophy. Am J Physiol 297:H523-H532
42. Hoque N, Cook MA, Karmazyn M (2000) Inhibition of a1-adrenergic-mediated responses in rat ventricular myocytes by adenosine A1 receptor activation: role of the KATP channel. J Pharmacol Exp Ther 294:770-777
43. Avkiran M, Yokoyama H (2000) Adenosine A1 receptor stimulation inhibits a1-adrenergic activation of the cardiac sarcolemmal Na+/H+ exchanger. Br J Pharmacol 131:659-662
44. Liao Y, Takashima S, Asano Y, Asakura M, Ogai A et al (2003) Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circ Res 93:759-766
45. Gan XT, Rajapurohitam V, Haist JV, Chidiac P, Cook MA et al (2005) Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes. J Pharmacol Exp Ther 312:27-34
46. Chen Y, Bache RJ (2003) Adenosine: a modulator of the cardiac response to stress. Circ Res 93:691-693
47. Funakoshi H, Chan TO, Good JC, Libonati JR, Piuhola J et al (2006) Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function. Circulation 114:2240-2250
48. Lu Z, Fassett J, Xu X, Hu X, Zhu G et al (2008) Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle. Circulation 118:1713-1721
49. Xu X, Fassett J, Hu X, Zhu G, Lu Z et al (2008) Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction. Hypertension 51:1557-1564
50. Aras D, Topaloglu S, Demirkan B, Deveci B, Ozeke O et al (2006) Porcelain heart: a case of massive myocardial calcification. Int J Cardiovasc Imaging 22:123-126
51. Itoh E, Saitoh H, Miida T, Oda H, Toeda T et al (1997) An autopsied case of acute myocarditis with myocardial calcification. Jpn Circ J 61:798-802
52. Schellhammer F, Ansén S, Arnold G, Brochhagen HG, Lackner K (2002) Myocardial calcification following septic shock. Cardiology 98:102-103
53. Bloom S, Peric-Golia L (1989) Geographic variation in the incidence of myocardial calcification associated with acute myocardial infarction. Hum Pathol 20:726-731
54. Segura AM, Radovancevic R, Connelly JH, Loyalka P, Gregoric ID et al (2011) Endomyocardial nodular calcification as a cause of heart failure. Cardiovasc Pathol 20:e185-e188
55. Barnard DC, Pape L, Missri J, Dalen JE (1985) Massive myocardial calcification and normal coronary arteries. Tex Heart Inst J 12:363-365
56. Trigo J, Camacho A, Gago P, Candeias R, Santos W et al (2010) Endomyocardial fibrosis with massive calcification of the left ventricle. Rev Port Cardiol 29:445-449
57. Canesin MF, Gama RF, Smith DL, Kazuma FJ, Takiuchi A et al (1999) Endomyocardial fibrosis associated with massive calcification of the left ventricle. Arq Bras Cardio 73:499-506
58. Morrone LF, Moreira AE, Lopez M, Kajita LJ, Potério DI et al (1996) Endomyocardial fibrosis with massive biventricular endocardial calcification. Arq Bras Cardiol 67:103-105
59. Rifai L, Hammoudi N, Fouret P, Acar C (2011) Massive calcification of the tricuspid valve papillary muscles in right ventricular endomyocardial fibrosis. Interact Cardiovasc Thorac Surg 12:505-506
60. Johnson RC, Leopold JA, Loscalzo J (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99:1044-1059
61. Hilaire SG, Ziegler T, Markello A, Brusco C, Groden F et al (2011) NT5E mutations and arterial calcifications. N Engl J Med 364:432-442
62. Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-5'- nucleotidase (CD73). Purinergic Signal 2:351-360
63. Millán JL (2006) Alkaline phosphatases: structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal 2:335-341
64. Mota A, Silva P, Neves D, Lemos C, Calhau C et al (2008) Characterization of rat heart alkaline phosphatase isoenzymes and modulation of activity. Braz J Med Biol Res 41:600-609
65. Martins MJ, Azevedo I (2010) Let's think in alkaline phosphatase at heart function. Int J Cardiol 144:333-334
66. Schultz-Hector S, Balz K, Böhm M, Ikehara Y, Rieke LJ (1993) Cellular localization of endothelial alkaline phosphatase reaction product and enzyme protein in the myocardium. Histochem Cytochem 41:1813-1821
67. Nakagami H, Osako MK, Morishita R (2011) New concept of vascular calcification and metabolism. Curr Vasc Pharmacol 9:124-127
68. Koulaouzidis G, Henein M (2011) Coronary calcification and hormones. Angiology 62:554-564
69. Sinha S, Eddington H, Kalra PA (2009) Vascular calcification: lessons from scientific models. J Ren Care 35(1):51-56
70. Prosdocimo DA, Wyler SC, Romani AM, O'Neill WC, Dubyak GR (2010) Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia. Am J Physiol Cell Physiol 298:C702-C713